Investment Risks - Grizzle Growth ETF
|
Nov. 20, 2026 |
| Growth Investing Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Growth
Investing Risk. Growth stocks can be volatile for several reasons. Since those companies usually invest a high portion of
earnings in their businesses, they may lack the dividends of value stocks that can cushion stock prices in a falling market. The
prices of growth stocks are based largely on projections of the issuer’s future earnings and revenues. If a company’s
earnings or revenues fall short of expectations, its stock price may fall dramatically.
|
| Style Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Style
Risk. If at any time the market is not favoring the Fund’s growth investment style, the Fund’s gains may not be
as big as, or its losses may be bigger than, those of other funds using different investment styles.
|
| Management Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Management
Risk. The Fund is actively managed using proprietary investment strategies and processes. There can be no guarantee that Grizzle’s
judgments about the attractiveness, value and potential appreciation of particular investments and strategies for the Fund will
be correct or produce the desired results or that the Fund will achieve its investment objective. If Grizzle fails to accurately
evaluate market risk or appropriately react to current and developing market conditions, the Fund’s share price may be adversely
affected.
|
| Sector Risks [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Sector
Risks. To the extent the Fund invests more heavily in particular sectors of the economy, its performance will be especially
sensitive to developments that significantly affect those sectors. The Fund may invest a significant portion of its assets in
the following sectors and, therefore, the performance of the Fund could be negatively impacted by events affecting each of these
sectors.
|
| Automobile Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Automobile
Sector. The Automobiles Industry can be highly cyclical, and companies in the industry may suffer periodic operating losses.
The Automobiles Industry also can be significantly affected by labor relations and fluctuating component prices. Companies
in the Automobiles Industry, particularly those engaged in the production of electric vehicles may be affected by the obsolescence
of existing technology, short product cycles, falling prices and profits, competition from new market entrants and general
economic conditions. While most of the major manufacturers are large, financially strong companies, many others are small
and can be non-diversified in both product line and customer base. Additionally, developments in automotive technologies (e.g.,
autonomous vehicle technologies) may require significant capital expenditures that may not generate profits for several years,
if any. Companies in the Automobiles Industry may be significantly subject to government policies and regulations regarding
imports and exports of automotive products. Governmental policies affecting the Automobiles Industry, such as taxes, tariffs,
duties, subsidies, and import and export restrictions on automotive products can influence industry profitability. In addition,
such companies must comply with environmental laws and regulations, for which there may be severe consequences for non-compliance.
Legislative or regulatory changes and increased government supervision also may affect companies in the Automobiles Industry. |
Autonomous
and electric vehicle companies typically engage in significant amounts of spending on research and development, capital expenditures
and mergers and acquisitions, and there is no guarantee that the products or services produced by these companies will be successful.
Companies that produce the raw materials that are used in electric vehicles may be concentrated in certain commodities, and therefore
be exposed to the price fluctuations of those commodities. In addition, autonomous vehicle technology could face increasing regulatory
scrutiny in the future, which may limit the development of this technology and impede the growth of companies that develop and/or
utilize this technology. Autonomous and electric vehicle companies are also potential targets for cyberattacks, which can have
a materially adverse impact on the performance of these companies. Autonomous and electric vehicle companies rely on artificial
intelligence and big data technologies for the development of their platforms and, as a result, could face increased scrutiny
as regulators consider how the data is collected, stored, safeguarded and used.
|
| Cannabis Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
|
| United States Regulatory Risks of the Cannabis Industry [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| ○ | United
States Regulatory Risks of the Cannabis Industry. Marijuana and marijuana-related activities remain subject to substantial
federal and state regulation. Certain FDA-approved products and state-licensed medical marijuana are classified in Schedule III
under federal law, while marijuana outside those categories generally remains in Schedule I. Use of marijuana is regulated by
both the federal government and state governments, and state and federal laws regarding marijuana often conflict. State authorization
alone does not establish compliance with all applicable federal requirements. Federal law criminalizing the use of marijuana pre-empts
state laws that legalize its use for medicinal and recreational purposes. Actions by federal agencies, such as increased enforcement
of current federal marijuana laws and the prosecution of nonviolent federal drug crimes by the U.S. Department of Justice (the
“DOJ”), could produce a chilling effect on the Cannabis Sector’s growth and discourage banks from expanding
their services to cannabis companies where such services are currently limited. Any of these outcomes would negatively affect
the profitability and value of the Fund’s investments and even its ability to pursue its stated investment objective. The
conflict between the regulation of marijuana under federal and state law creates volatility and risk for all cannabis companies. |
Marijuana
outside the categories transferred to Schedule III remains a Schedule I controlled substance under the Controlled Substances Act
(the “CSA”). Few drug products containing cannabis or cannabis extracts have been approved for use by the U.S. Food
and Drug Administration (the “FDA”) or obtained registrations for commercial production from the U.S. Drug Enforcement
Administration (the “DEA”), and there is no guarantee that such products will ever be legally produced or sold in
the United States. Cannabis companies in the United States that engage in research, manufacturing, distributing, importing or
exporting, or dispensing controlled substances must be registered (licensed) to perform these activities and have the security,
control, recordkeeping, reporting and inventory mechanisms required by the DEA to prevent drug loss and diversion. Failure to
obtain the necessary registrations or to comply with necessary regulatory requirements may significantly impair the ability of
certain companies in which the Fund invests to pursue medical marijuana research or to otherwise cultivate, possess or distribute
marijuana. For businesses trafficking in substances classified in Schedule I or II, Section 280E of the Internal Revenue Code
of 1986, as amended (the “Internal Revenue Code”) applies by its terms to the purchase and sale of medical-use cannabis
products and provides that no deduction or credit is allowed for expenses incurred during a taxable year “in carrying on
any trade or business if such trade or business (or the activities which comprise such trade or business) consists of trafficking
in controlled substances (within the meaning of Schedules I and II of the CSA) which is prohibited by federal law or the law of
any state in which such trade or business is conducted.” The disallowance of such tax deductions will likely affect the
value of cannabis companies.
|
| Non-U.S. Regulatory Risks of the Cannabis Industry [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
○ |
Non-U.S.
Regulatory Risks of the Cannabis Industry. Laws and regulations related to the possession, use (medical and recreational),
sale, transport and cultivation of marijuana vary throughout the world, and the Fund will only invest in non-U.S. cannabis
companies if such companies are operating legally in the relevant jurisdiction. Even if a company’s operations are permitted
under current law, they may not be permitted in the future, in which case such company may not be in a position to carry on
its operations in its current locations. Additionally, controlled substance legislation differs between countries and legislation
in certain countries may restrict or limit the ability of certain companies in which the Fund invests to sell their products. |
|
| Operational Risks of the Cannabis Industry [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
○ |
Operational
Risks of the Cannabis Industry. Companies involved in the Cannabis Sector face intense competition, may have limited
access to the services of banks, may have substantial burdens on company resources due to litigation, complaints or enforcement
actions, and are heavily dependent on receiving necessary permits and authorizations to engage in medical cannabis research
or to otherwise cultivate, possess or distribute cannabis. Because certain cannabis-related activities remain prohibited or
restricted under United States federal law, federally regulated banking institutions may be unwilling to make financial services
available to growers and sellers of cannabis. |
|
| Communications Services Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Communications
Services Sector. Companies in the Communications Services Sector are subject to extensive government regulation. The costs
of complying with governmental regulations, delays or failure to receive required regulatory approvals, or the enactment of
new adverse regulatory requirements may adversely affect the business of such companies. Companies in the Communications Services
Sector also can be significantly affected by intense competition, including competition with alternative technologies such
as wireless communications (including with 5G and other technologies), product compatibility, consumer preferences, rapid
product obsolescence, and research and development of new products. Technological innovations may make the products and services
of such companies obsolete. Media content creation carries risks of changing consumer tastes and running afoul of FCC content
guidelines, which could result in large fines or the loss of regulatory licenses. Media companies collect significant amounts
of personal consumer data and are at risk of data breaches and fines for the unauthorized and unplanned public release of
sensitive consumer data. |
|
| Energy Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Energy
Sector. The Energy Sector is comprised of energy, industrial, infrastructure, and logistics companies, and, therefore,
the Fund is susceptible to the adverse economic, environmental, business, regulatory, or other occurrences affecting the Energy
Sector. The Energy Sector has historically experienced substantial price volatility. At times, the performance of companies
within the Energy Sector may lag the performance of companies operating within other sectors or the market as a whole. Companies
operating in the Energy Sector are subject to specific risks, including, among others, fluctuations in commodity prices; reduced
consumer demand for commodities such as oil, natural gas, or petroleum products; reduced availability of natural gas or other
commodities for transporting, processing, storing, or delivering; slowdowns in new construction; extreme weather or other
natural disasters; and threats of attack by terrorists on energy assets. Additionally, companies within the Energy Sector
are subject to substantial government regulation and oversight and changes in the regulatory environment for energy companies
may adversely impact their profitability and thus, the Fund’s performance. Over time, depletion of natural gas reserves
and other energy reserves also may affect the profitability of energy companies. |
|
| Financial Services Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Financial
Services Sector. The Financial Services Sector can be significantly affected by changes in interest rates, government
regulation, the rate of defaults on corporate, consumer and government debt, the availability and cost of capital, and fallout
from the housing and sub-prime mortgage crisis. Insurance companies, in particular, may be significantly affected by changes
in interest rates, catastrophic events, price and market competition, the imposition of premium rate caps, or other changes
in government regulation or tax law and/or rate regulation, which may have an adverse impact on their profitability. The Financial
Services Sector has experienced significant losses in the recent past, and the impact of more stringent capital requirements
and of recent or future regulation on any individual financial company or on the sector as a whole cannot be predicted. In
recent years, cyber-attacks and technology malfunctions and failures have become increasingly frequent in this sector and
have caused significant losses. |
|
| Healthcare Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Healthcare
Sector. Companies in the Healthcare Sector are subject to extensive government regulation and their profitability can
be significantly affected by restrictions on government reimbursement for medical expenses, rising costs of medical products
and services, pricing pressure (including price discounting), limited product lines, and an increased emphasis on the delivery
of healthcare through outpatient services. The costs associated with developing new drugs can be significant, and the results
are unpredictable. Newly developed drugs may be susceptible to product obsolescence due to intense competition from new products
and less costly generic products. Moreover, the process for obtaining regulatory approval by the FDA or other governmental
regulatory authorities is long and costly and there can be no assurance that the necessary approvals will be obtained or maintained.
The values of many companies in the Healthcare Sector also are dependent on the development, protection and exploitation of
intellectual property rights and other proprietary information, and the profitability of these companies may be significantly
affected by such things as the expiration of patents or the loss of, or the inability to enforce, intellectual property rights. |
|
| Industrials Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Industrials
Sector. Companies in the Industrials Sector can be significantly affected by supply and demand for specific products or
services and for Industrials Sector products in general; a decline in demand for products due to rapid technological developments
and frequent new product introduction; government regulation, world events and economic conditions; and the risks associated
with potential environmental damage and product liability claims. |
|
| Information Technology Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Information
Technology Sector. The information technology sector has recently experienced significant disruptions caused by artificial
intelligence (“AI”) related events, including layoffs and workforce re-alignments related to AI advancements and
AI-related spending and escalating AI-enabled cyberattacks and data breaches. These events have led to significant market
volatility and stock declines for certain software, cybersecurity, and other companies within this sector. Market or economic
factors impacting information technology companies and companies that rely heavily on technological advances could have a
significant effect on the value of the Fund’s investments. The value of stocks of information technology companies and
companies that rely heavily on technology is particularly vulnerable to rapid changes in technology product cycles, rapid
product obsolescence, government regulation and competition, both domestically and internationally, including competition
from foreign competitors with lower production costs. Stocks of information technology companies and companies that rely heavily
on technology, especially those of smaller, less-seasoned companies, tend to be more volatile than the overall market. Information
technology companies are heavily dependent on patent and intellectual property rights, the loss or impairment of which may
adversely affect profitability. Information technology companies and companies that rely heavily on technology also may be
prone to operational and information security risks resulting from cyber-attacks and/or technological malfunctions. |
|
| Materials Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Materials
Sector. Companies in the Materials Sector may be adversely impacted by the volatility of commodity prices, changes in exchange
rates, depletion of resources, over-production, litigation and changes in government regulations, among other factors. |
|
| Media and Entertainment Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Media
and Entertainment Sector. Media and entertainment companies, including companies engaged in the design, production or
distribution of goods or services for the media and entertainment industries (including video game publishing, creating interactive
worlds and e-sports) may become obsolete quickly. Media and entertainment companies are subject to risks that include cyclicality
of revenues and earnings, a decrease in the discretionary income of targeted individuals, changing consumer tastes and interests,
fierce competition in the industry and the potential for increased government regulation. Media and entertainment company
revenues largely are dependent on advertising spending. A weakening general economy or a shift from online to other forms
of advertising may lead to a reduction in discretionary spending on online advertising. Additionally, competitive pressures
and government regulation can significantly affect media and entertainment companies. |
|
| Psychedelics Sector [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
● |
Psychedelics
Sector. Psychedelics companies are subject to various laws and regulations that may differ at the state/local and federal
levels. These laws and regulations may significantly affect a psychedelics company’s ability to secure financing, impact
the market for psychedelics business sales and services, and set limitations on psychedelics use, production, transportation,
and storage. There can be no guarantees that such approvals or administrative actions will happen or be favorable for psychedelics
companies, and such actions may be subject to lengthy delays, and may require lengthy and expensive clinical trials. Additionally,
therapies containing controlled substances may generate public controversy. Political and social pressures and adverse publicity
could lead to delays in approval of, and increased expenses for, psychedelics companies and any future therapeutic candidates
they may develop. All of these factors and others may prevent psychedelics companies from becoming profitable, which may materially
affect the value of certain Fund investments. In addition, psychedelics companies are subject to the risks associated with
the biotechnology and pharmaceutical industries. |
In
Canada, certain psychedelic drugs, including psilocybin, are classified as Schedule III drugs under the Controlled Drugs and Substances
Act (the “CDSA”) and activities involving these substances are illegal under Canadian federal law unless authorized
by Health Canada, including through applicable licences, exemptions, clinical trials or the Special Access Program. In the United
States, most psychedelic drugs, including psilocybin, are classified as Schedule I drugs under the CSA and the Controlled Substances
Import and Export Act (the “CSIEA”) and, as such, medical and recreational use is illegal under the U.S. federal laws.
There is no guarantee that psychedelic drug products being developed by portfolio companies will obtain the approvals required
for their intended uses in either jurisdiction.
In
the United States, DEA scheduling determinations removing a substance from Schedule I are dependent on FDA approval of a substance
or a specific formulation of a substance for a therapeutic or medicinal use. Unless and until psilocybin, psilocin, or other psychedelics-based
products receive FDA approval, such products are prohibited from sale, which limits the growth opportunities for certain portfolio
companies of the Fund. Even if approved by the FDA, the manufacture, importation, exportation, domestic distribution, storage,
sale, and legitimate use of such products will continue to be subject to a significant degree of regulation by the DEA. There
can be no guarantee that such approvals or administrative actions will happen or be favorable for psychedelics companies. Such
actions may be subject to lengthy delays and may require lengthy and expensive clinical trials. Additionally, therapies containing
controlled substances may generate public controversy and carry reputational risk. Political and social pressures and adverse
publicity could lead to delays in approval of, and increased expenses for, psychedelics companies and any future therapeutic candidates
they may develop. Psychedelics companies also are subject to the risks associated with the Biotechnology and Pharmaceutical Industries.
In addition, because certain psychedelic drugs, including psilocybin, are a Schedule I controlled substance, Section 280E of the
Internal Revenue Code applies by its terms to the purchase and sale of such psychedelic drugs and provides that no deduction or
credit is allowed for expenses incurred during a taxable year “in carrying on any trade or business if such trade or business
(or the activities which comprise such trade or business) consists of trafficking in controlled substances (within the meaning
of Schedules I and II of the CSA) which is prohibited by federal law or the law of any state in which such trade or business is
conducted.” The disallowance of such tax deductions will likely affect the value of psychedelic drug-related companies.
All of these factors and others may prevent psychedelics companies from becoming profitable, which may materially affect the value
of certain Fund investments.
|
| Foreign Securities Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Foreign
Securities Risk. Investments in securities or other instruments of non-U.S. issuers involve certain risks not involved in
domestic investments and may experience more rapid and extreme changes in value than investments in securities of U.S. companies.
Financial markets in foreign countries often are not as developed, efficient, or liquid as financial markets in the United States,
and therefore, the prices of non-U.S. securities and instruments can be more volatile. In addition, the Fund will be subject to
risks associated with adverse political and economic developments in foreign countries, which may include the imposition of economic
sanctions. Generally, there is less readily available and reliable information about non-U.S. issuers due to less rigorous disclosure
or accounting standards and regulatory practices.
|
| Derivatives Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Derivatives
Risk. Derivatives are financial instruments that derive value from the underlying reference asset or assets, such as stocks,
bonds, commodities, currencies, funds (including ETFs), interest rates or indexes. The Fund’s investments in derivatives
may pose risks in addition to, and greater than, those associated with directly investing in securities or other ordinary investments,
including risk related to the market, imperfect correlation with underlying investments or the Fund’s other portfolio holdings,
higher price volatility, lack of availability, counterparty risk, liquidity, valuation and legal restrictions. The use of derivatives
is a highly specialized activity that involves investment techniques and risks different from those associated with ordinary portfolio
securities transactions. The use of derivatives may result in larger losses or smaller gains than directly investing in the underlying
reference asset(s). Because derivatives often require only a limited initial investment, the use of derivatives may expose the
Fund to losses in excess of those amounts initially invested. In addition, the Fund’s investments in derivatives are subject
to the following risks:
|
| Options Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| ● | Options
Risk. The prices of options may change rapidly over time and do not necessarily move in tandem with the price of the underlying
securities. Selling call options reduces the Fund’s ability to profit from increases in the value of the Fund’s equity
portfolio, and purchasing put options may result in the Fund’s loss of premiums paid in the event that the put options expire
unexercised. To the extent that the Fund reduces its put option holdings relative to the number of call options sold by the Fund,
the Fund’s ability to mitigate losses in the event of a market decline will be reduced. |
|
| Counterparty Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Counterparty
Risk. To the extent contemplated by its investment strategy, the Fund may use derivative instruments, such as options, swaps,
futures contracts and other instruments, to obtain or manage investment exposure. Derivatives may be subject to counterparty risk,
meaning the risk that a counterparty, clearing member or clearing house will be unwilling or unable to perform its obligations
to the Fund due to bankruptcy, insolvency, financial distress, operational failure or other default. If a counterparty or clearing
member defaults, the Fund may lose the expected benefit of the transaction, experience delays or costs in recovering collateral
or other amounts owed to it, or be required to enter into replacement transactions on less favorable terms, if at all. The Fund
also may be unable to implement its investment strategy effectively if suitable counterparties or clearing members are unavailable.
|
| Depositary Receipt Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Depositary
Receipt Risk. Depositary receipts involve risks similar to those associated with investments in foreign securities and give
rise to certain additional risks. Depositary receipts listed on U.S. or foreign exchanges are issued by banks or trust companies,
and entitle the holder to all dividends and capital gains that are paid out on the underlying foreign shares (“Underlying
Shares”). When the Fund invests in depositary receipts as a substitute for an investment directly in the Underlying Shares,
the Fund is exposed to the risk that the depositary receipts may not provide a return that corresponds precisely with that of
the Underlying Shares.
|
| Emerging Markets Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Emerging
Markets Risk. The Fund may invest indirectly, via ADRs, in securities issued by companies domiciled or headquartered in emerging
market nations. Investments in securities traded in developing or emerging markets, or that provide exposure to such securities
or markets, can involve additional risks relating to political, economic, currency, or regulatory conditions not associated with
investments in U.S. securities and investments in more developed international markets. Such conditions may impact the ability
of the Fund to buy, sell or otherwise transfer securities, adversely affect the trading market and price for Fund Shares and cause
the Fund to decline in value.
|
| Equity Market Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Equity
Market Risk. Common stocks are generally exposed to greater risk than other types of securities, such as preferred stock and
debt obligations, because common stockholders generally have inferior rights to receive payment from specific issuers. The equity
securities held in the Fund’s portfolio may experience sudden, unpredictable drops in value or long periods of decline in
value. This may occur because of factors that affect securities markets generally or factors affecting specific issuers, industries,
or sectors in which the Fund invests.
|
| ETF Risks [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
ETF
Risks.
|
| Authorized Participants, Market Makers, and Liquidity Providers Concentration Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
○ |
Authorized
Participants, Market Makers, and Liquidity Providers Concentration Risk. The Fund
has a limited number of financial institutions that are authorized to purchase and redeem
Shares directly from the Fund (known as “Authorized Participants” or “APs”).
In addition, there may be a limited number of market makers and/or liquidity providers
in the marketplace. To the extent either of the following events occur, Shares may trade
at a material discount to NAV and possibly face delisting: (i) APs exit the business
or otherwise become unable to process creation and/or redemption orders and no other
APs step forward to perform these services; or (ii) market makers and/or liquidity providers
exit the business or significantly reduce their business activities and no other entities
step forward to perform their functions. |
|
| Cash Redemption Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| |
|
Cash
Redemption Risk. The Fund’s investment strategy may require it to redeem Shares for cash or to otherwise include cash
as part of its redemption proceeds. For example, the Fund may not be able to redeem in-kind certain securities held by the Fund
(e.g., derivative instruments). In such a case, the Fund may be required to sell or unwind portfolio investments to obtain the
cash needed to distribute redemption proceeds. This may cause the Fund to recognize a capital gain that it might not have recognized
if it had made a redemption in-kind. As a result, the Fund may pay out higher annual capital gain distributions than if the in-kind
redemption process was used. By paying out higher annual capital gain distributions, investors may be subjected to increased capital
gains taxes. The costs associated with cash redemptions may include brokerage costs that the Fund may not have incurred if it
had made the redemptions in-kind. These costs could be imposed on the Fund, decreasing its NAV, to the extent these costs are
not offset by a transaction fee payable by an authorized participant. |
|
| Costs of Buying or Selling Shares [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| ○ | Costs
of Buying or Selling Shares. Due to the costs of buying or selling Shares, including brokerage commissions imposed by
brokers and bid-ask spreads, frequent trading of Shares may significantly reduce investment results and an investment in Shares
may not be advisable for investors who anticipate regularly making small investments. |
|
| Shares May Trade at Prices Other Than NAV [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| ○ | Shares
May Trade at Prices Other Than NAV. As with all ETFs, Shares may be bought and sold in the secondary market at market prices.
Although it is expected that the market price of Shares will approximate the Fund’s NAV, there may be times when the market
price of Shares is more than the NAV intra-day (premium) or less than the NAV intra-day (discount) due to supply and demand of
Shares or during periods of market volatility. This risk is heightened in times of market volatility, periods of steep market
declines, and periods when there is limited trading activity for Shares in the secondary market, in which case such premiums or
discounts may be significant. Because securities held by the Fund may trade on foreign exchanges that are closed when the Fund’s
primary listing exchange is open, the Fund is likely to experience premiums and discounts greater than those of ETFs holding only
domestic securities. |
|
| Trading [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| ○ | Trading.
Although Shares are listed for trading on a national securities exchange, such as NYSE Arca, Inc. (the “Exchange”),
and may be traded on U.S. exchanges other than the Exchange, there can be no assurance that Shares will trade with any volume,
or at all, on any stock exchange. In stressed market conditions, the liquidity of Shares may begin to mirror the liquidity of
the Fund’s portfolio holdings, which can be significantly less liquid than Shares. |
|
| Economic and Market Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Economic
and Market Risk. Economies and financial markets throughout the world are becoming increasingly interconnected, which increases
the likelihood that events or conditions in one country or region will adversely impact markets or issuers in other countries
or regions. Securities in the Fund’s portfolio may underperform in comparison to securities in the general financial markets,
a particular financial market, or other asset classes, due to a number of factors, including inflation (or expectations for inflation),
deflation (or expectations for deflation), interest rates, global demand for particular products or resources, market instability,
financial system instability, debt crises and downgrades, embargoes, tariffs, sanctions and other trade barriers, regulatory events,
other governmental trade or market control programs and related geopolitical events. In addition, the value of the Fund’s
investments may be negatively affected by the occurrence of global events such as war, terrorism, environmental disasters, natural
disasters or events, country instability, and infectious disease epidemics or pandemics. The imposition by the U.S. of tariffs
on goods imported from foreign countries and reciprocal tariffs levied on U.S. goods by those countries also may lead to volatility
and instability in domestic and foreign markets.
|
| Geographic Investment Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Geographic
Investment Risk. To the extent the Fund invests a significant portion of its assets in the securities of companies of a single
country or region, it is more likely to be impacted by events or conditions affecting that country or region.
|
| Canada-Specific Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| ● | Canada-Specific
Risk. Because investments in the metals and mining industry may be geographically concentrated in Canadian companies or companies
that have a significant presence in Canada, investment results could be dependent on the financial condition of the Canadian economy.
The Canadian economy is reliant on the sale of natural resources and commodities, which can pose risks such as the fluctuation
of prices and the variability of demand for exportation of such products. Changes in spending on Canadian products by the economies
of other countries or changes in any of these economies may cause a significant impact on the Canadian economy. |
|
| High Portfolio Turnover Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
High
Portfolio Turnover Risk. The Fund may actively and frequently trade all or a significant portion of the securities in its
portfolio. A high portfolio turnover rate increases transaction costs, which may increase the Fund’s expenses. Frequent
trading may also cause adverse tax consequences for investors in the Fund due to an increase in short-term capital gains.
|
| Market Capitalization Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Market
Capitalization Risk.
|
| Large-Capitalization Investing [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| ● | Large-Capitalization
Investing. The securities of large-capitalization companies may be relatively mature compared to smaller companies and therefore
subject to slower growth during times of economic expansion. Large-capitalization companies may also be unable to respond quickly
to new competitive challenges, such as changes in technology and consumer tastes. |
|
| Mid-Capitalization Investing [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| ● | Mid-Capitalization
Investing. The securities of mid-capitalization companies may be more vulnerable to adverse issuer, market, political, or
economic developments than securities of large-capitalization companies. The securities of mid-capitalization companies generally
trade in lower volumes and are subject to greater and more unpredictable price changes than large capitalization stocks or the
stock market as a whole. Some medium capitalization companies have limited product lines, markets, financial resources, and management
personnel and tend to concentrate on fewer geographical markets relative to large-capitalization companies. |
|
| Small-Capitalization Investing [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
| ● | Small-Capitalization
Investing. The securities of small-capitalization companies may be more vulnerable to adverse issuer, market, political, or
economic developments than securities of larger-capitalization companies. The securities of small-capitalization companies generally
trade in lower volumes and are subject to greater and more unpredictable price changes than larger capitalization stocks or the
stock market as a whole. Some small capitalization companies have limited product lines, markets, and financial and managerial
resources and tend to concentrate on fewer geographical markets relative to large- or mid-capitalization companies. There is typically
less publicly available information concerning smaller-capitalization companies than for larger, more established companies. Small-capitalization
companies also may be particularly sensitive to changes in interest rates, government regulation, borrowing costs and earnings. |
|
| Models and Data Risk [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Models
and Data Risk. When models and data prove to be incorrect or incomplete, any decisions made in reliance thereon expose the
Fund to potential risks. Some of the models used to construct the Fund are predictive in nature. The use of predictive models
has inherent risks. For example, such models may incorrectly forecast future behavior, leading to potential losses. In addition,
in unforeseen or certain low-probability scenarios (often involving a market disruption of some kind), such models may produce
unexpected results, which can result in losses for the Fund. Furthermore, because predictive models are usually constructed based
on historical data supplied by third parties, the success of relying on such models may depend heavily on the accuracy and reliability
of the supplied historical data.
|
| Risk Lose Money [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
As with any investment, there is a risk that you could lose all
or a portion of your investment in the Fund.
|
| Risk Nondiversified Status [Member] |
|
| Prospectus [Line Items] |
|
| Risk [Text Block] |
Non-Diversification
Risk. Because the Fund is non-diversified, it may invest a greater percentage of its assets in the securities of a single
issuer or a smaller number of issuers than if it was a diversified fund. As a result, a decline in the value of an investment
in a single issuer or a smaller number of issuers could cause the Fund’s overall value to decline to a greater degree than
if the Fund held a more diversified portfolio. This may increase the Fund’s volatility and cause the performance of a relatively
smaller number of issuers to have a greater impact on the Fund’s performance.
|